2-环已基-1-丙醇 | 5442-00-2

• 物质功能分类: 有机原料 - 醇、酚、酚醇类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 2-环已基-1-丙醇
• 中文别名: 2-环己基-1-丙醇；β-甲基环己乙醇；-甲基环己乙醇
• 英文名称: 2-cyclohexylpropan-1-ol
• 英文别名: 2-methyl-2-cyclohexylethanol；2-cyclohexylpropanol；2-cyclohexyl-1-propanol；2-cyclohexyl propanol；(+/-)-2-cyclohexyl-propan-1-ol；(3-cyclohexyl)-propanol
• CAS: 5442-00-2
• 化学式: C₉H₁₈O
• 分子量: 142.241
• InChiKey: IRIVQXLOJHCXIE-UHFFFAOYSA-N

物化性质

• 沸点：
  219.85°C (rough estimate)
• 密度：
  0.9000
• LogP：
  2.655 (est)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  10
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2906199090

SDS

Name:	2-Cyclohexyl-1-Propanol 99% Material Safety Data Sheet
Synonym:	Cyclohexaneethanol, Beta.-Methyl-
CAS:	5442-00-2

Section 1 - Chemical Product MSDS Name:2-Cyclohexyl-1-Propanol 99% Material Safety Data Sheet
Synonym:Cyclohexaneethanol, Beta.-Methyl-

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
5442-00-2	Cyclohexaneethanol, Beta.-Methyl-	99	226-632-9

Hazard Symbols: None Listed.
Risk Phrases: None Listed.

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
The toxicological properties of this material have not been fully investigated.
Potential Health Effects
Eye:
May cause eye irritation.
Skin:
May cause skin irritation.
Ingestion:
May cause irritation of the digestive tract. The toxicological properties of this substance have not been fully investigated.
Inhalation:
May cause respiratory tract irritation. The toxicological properties of this substance have not been fully investigated.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use water spray to keep fire-exposed containers cool. Water may be ineffective.
Material is lighter than water and a fire may be spread by the use of water. Vapors may be heavier than air. They can spread along the ground and collect in low or confined areas. Containers may explode when heated.
Extinguishing Media:
Water may be ineffective. Use agent most appropriate to extinguish fire. Cool containers with flooding quantities of water until well after fire is out. Use water spray, dry chemical, carbon dioxide, or appropriate foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Avoid runoff into storm sewers and ditches which lead to waterways.
Clean up spills immediately, observing precautions in the Protective Equipment section. Absorb spill using an absorbent, non-combustible material such as earth, sand, or vermiculite. Do not use combustible materials such as sawdust. Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Wash thoroughly after handling. Remove contaminated clothing and wash before reuse. Use with adequate ventilation. Avoid contact with eyes, skin, and clothing. Keep container tightly closed. Avoid ingestion and inhalation.
Storage:
Store in a tightly closed container. Store in a cool, dry, well-ventilated area away from incompatible substances.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 5442-00-2: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
A respiratory protection program that meets OSHA's 29 CFR 1910.134 and ANSI Z88.2 requirements or European Standard EN 149 must be followed whenever workplace conditions warrant respirator use.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Liquid
Color: clear, colorless
Odor: alcohol-like
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density: .9080g/cm3
Molecular Formula: C9H18O
Molecular Weight: 142.24

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable under normal temperatures and pressures.
Conditions to Avoid:
Incompatible materials, excess heat, strong oxidants.
Incompatibilities with Other Materials:
Oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, irritating and toxic fumes and gases, carbon dioxide.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 5442-00-2 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
Cyclohexaneethanol, Beta.-Methyl- - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Not regulated as a hazardous material.
IMO
Not regulated as a hazardous material.
RID/ADR
Not regulated as a hazardous material.

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: Not available.
Risk Phrases:
Safety Phrases:
S 24/25 Avoid contact with skin and eyes.
S 28A After contact with skin, wash immediately with
plenty of water.
S 37 Wear suitable gloves.
S 45 In case of accident or if you feel unwell, seek
medical advice immediately (show the label where
possible).
WGK (Water Danger/Protection)
CAS# 5442-00-2: No information available.
Canada
CAS# 5442-00-2 is listed on Canada's DSL List.
CAS# 5442-00-2 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 5442-00-2 is listed on the TSCA inventory.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  2-环已基-1-丙醇 在 palladium on activated charcoal 吡啶 、 氢气 、 sodium iodide 、 lithium hexamethyldisilazane 作用下， 以 甲醇 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 反应 10.58h， 生成 (3aR,4R,6R,6aR)-6-(3-cyclohexylbutyl)-4-methoxy-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxole
  参考文献：
  名称：

  Francis, George W.; Papaioannou, Dionissios; Aksnes, Dagfinn W., Acta Chemica Scandinavica, 1991, vol. 45, # 6, p. 652 - 654

  摘要：

  DOI：
• 作为产物：
  描述：

  亚乙基环己烷 在 sodium tetrahydroborate 、 dicarbonylacetylacetonato rhodium (I) 、 C₃₇H₅₀NO₄P 、 氢气 作用下， 以 甲苯 为溶剂， 100.0 ℃ 、2.0 MPa 条件下， 反应 12.0h， 生成 2-环已基-1-丙醇
  参考文献：
  名称：

  三取代烯烃的配体控制的直接氢甲酰化

  摘要：

  通过Rh（I）催化剂和π-受体磷（briphos）配体的组合已实现了三取代烯烃的直接加氢甲酰化。发现具有与Rh（I）形成1∶1配合物的大锥角的空间庞大的Briphos配体对三取代的烯烃的加氢甲酰化是反应性的。所获得的醛产物具有高非对映选择性（> 99：1）和区域选择性（49％–81％）。

  DOI：

  10.1021/acs.orglett.9b01639

文献信息

• Chiral monodentate phosphine ligands for the enantioselective α- and γ-arylation of aldehydes
  作者：Ivan Franzoni、Laure Guénée、Clément Mazet

  DOI：10.1016/j.tet.2014.02.079

  日期：2014.7

  phosphine ligands elaborated on the binepine scaffold is described. Their application in the Pd-catalyzed intramolecular asymmetric α-arylation of aldehydes and the intermolecular asymmetric γ-arylation of α,β-unsaturated aldehydes provides a mean of validating the design of these ligands. For the first reaction, excellent reactivities have been obtained while only modest enantioselectivities were measured

  描述了合成在binepine支架上的单齿三烷基和二烷基联芳基膦配体的手性变异体的合成。它们在钯的钯催化的分子内不对称α-芳基化和α，β-不饱和醛的分子间不对称γ-芳基化中的应用提供了验证这些配体设计的手段。对于第一反应，获得了优异的反应性，而仅测量了适度的对映选择性。除了对映选择性之外，第二反应还提供了与分子内和区域选择性相关的其他挑战。有了正式的手性三烷基单齿膦配体，可以获得良好的收率，高烯烃立体控制和完美的γ选择性，而对映选择性仍处于较低但有希望的范围内。
• Cu‐Catalyzed Hydroxymethylation of Unactivated Alkyl Iodides with CO To Provide One‐Carbon‐Extended Alcohols
  作者：Siling Zhao、Neal P. Mankad

  DOI：10.1002/anie.201801814

  日期：2018.5.14

  We have developed a reductive carbonylation method by which unactivated alkyl iodides can be hydroxymethylated to provide one‐carbon‐extended alcohol products under Cu‐catalyzed conditions. The method is tolerant of alkyl β‐hydrogen atoms, is robust towards a wide variety of functional groups, and was applied to primary, secondary, and tertiary alkyl iodide substrates. Mechanistic experiments indicate

  我们已经开发了一种还原性羰基化方法，通过该方法可以将未活化的烷基碘进行羟甲基化，从而在Cu催化的条件下提供碳扩展的醇产物。该方法可耐受烷基β-氢原子，对多种官能团均具有较强的耐受性，并已应用于伯，仲和叔烷基碘的底物。机理实验表明，转化是通过烷基碘的原子转移羰基化（ATC）进行的，随后是两次CuH介导的快速连续还原。这种自由基机理使铜催化体系与贵金属催化的还原羰基化反应互补。
• [EN] BIARYL PYRAZOLES AS NRF2 REGULATORS<br/>[FR] BIARYL PYRAZOLES UTILISÉS COMME RÉGULATEURS DE NRF2
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2017060854A1

  公开（公告）日：2017-04-13

  The present invention relates to biaryl pyrazole compounds, methods of making them, pharmaceutical compositions containing them and their use as NRF2 regulators.

  本发明涉及双芳基吡唑化合物、它们的制备方法、含有它们的药物组合物及其作为NRF2调节剂的应用。
• [EN] 3-(2-ALKOXYCARBONYLOXY-PHENYL) ACRYLIC ACID ESTERS AND THEIR USE AS PRECURSORS FOR THE DELIVERY OF OLFACTORY COMPOUNDS<br/>[FR] ESTERS D'ACIDE 3-(2-ALCOXYCARBONYLOXY-PHENYL) ACRYLIQUE ET LEUR UTILISATION COMME PRECURSEURS POUR L'ADMINISTRATION DE COMPOSES OLFACTIFS
  申请人：GIVAUDAN SA

  公开号：WO2005077881A1

  公开（公告）日：2005-08-25

  A compound of formula (I), their use as precursors and a method of their production wherein n, Y, R, R2, R3, and R4 has the same meaning as given in the specification.

  一种具有式（I）的化合物，它们作为前体的用途以及它们的制备方法，其中n、Y、R、R2、R3和R4的含义与规范中给出的含义相同。
• [EN] NRF2 REGULATORS<br/>[FR] RÉGULATEURS DE NRF2
  申请人：GLAXOSMITHKLINE IP DEV LTD

  公开号：WO2016202253A1

  公开（公告）日：2016-12-22

  Provided are aryl analogs，pharmaceutical compositions containing them and their use as NRF2 regulators.

  提供芳基类似物，含有它们的药物组合物以及它们作为NRF2调节剂的用途。

表征谱图